graduate institute of anatomy and cell biology g-protein...

1

G-protein-coupled receptors (GPCRs)

黃敏銓mchuang@ntu.edu.tw

Graduate Institute of Anatomy and Cell Biology

台大醫學院 解剖學暨細胞生物學研究所

黃敏銓老師實驗室

Graduate Institute of Anatomy and Cell Biology

2

The Nobel Prize in Chemistry 2012 is awarded to Brian K. Kobilka (57) and Robert J. Lefkowitz (69) for studies of GPCRs.

3

G-protein-coupled receptors (GPCRs)

名稱 & 特徵

4

CCR5

G protein-coupled receptors (GPCRs) Seven transmembrane receptors (7 TM receptors) Heptahelical receptors Serpentine receptors

名 稱

5

Single Transmembrane Spanning Heterotrimeric GProtein-Coupled Receptors

Pharmacol Rev. 2004 Sep;56(3):371-85.

6

Characteristics of GPCRs

7 transmembrane domains

3 intracellular loops

3 extracellular loopsCytoplasmic

ExtracellularNH2

HOOC

A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling.GPR30 is uniquely localized to the endoplasmic reticulumRevankar CM et al., Science. 2005. 307:1625.

7

G-protein-coupled receptors (GPCRs)

Genomics: > 800 members

wide range of cellular activities

from yeast to human

50% drug target

8

G-protein-coupled receptors (GPCRs)

分類

9

G-protein-coupled receptor (GPCR) families

• Class A Rhodopsin like

• Class B Secretin like

• Class C Metabotropic glutamate / pheromone

• Class D Fungal pheromone

• Class E cAMP receptors (Dictyostelium)

• Frizzled/Smoothened family

10

Family classification of known GPCRs

NATURE REVIEWS | DRUG DISCOVERY VOLUME 1 | AUGUST 2002 | 599-608

11

NATURE REVIEWS | DRUG DISCOVERY VOLUME 1 | OCTOBER 2002 | 808-820

The three main families of GPCRs

12

GRAFS system Five main classes: Glutamate, Rhodopsin, Adhesion, Frizzled, and Secretin

Annu Rev Pharmacol Toxicol. 2013;53:127-46

Orphan receptors(unknown ligands)

13

G-protein-coupled receptors (GPCRs)

訊息傳遞

14

http://stke.sciencemag.org/content/vol0/issue2002/images/data/CMP_6634/DC1/science3.jpg, by R. Iyengar's laboratory

15

Summary of GPCR signalling

NATURE | VOL 415 | 10 JANUARY 2002 206-212

16

G protein action

GPCR

ligand1.

GDP βγα

2.

αβγ

GTP

GDP

GPCR(GEF)

second messenger

αβγ

GTP

3.

(GAP)

effectorGPCR

β

4.

αγGDP

Pi

stops

GPCR

G protein cycle for the β2AR–Gs complex

17

Nature. 2011 Jul 19;477(7366):549-55.

Kobilka’s group

18

NATURE REVIEWS | MOLECULAR CELL BIOLOGY VOLUME 3 | SEPTEMBER 2002 | 639-650

A classical example of GPCR signalling

19

Modified from TRENDS in Pharmacological Sciences Vol.22 No.7 July 2001, 368-376

GPCR G protein effector activities

4 大類

20

Regulation of systemic functions by signaling through G protein pathways

31 MAY 2002 VOL 296 SCIENCE, 1636-1639

21

NATURE REVIEWS | DRUG DISCOVERY VOLUME 1 | MARCH 2002 | 188

Heterotrimeric G-protein α-subunit subfamilies and their effects

22

G-protein-coupled receptors (GPCRs)

Desensitization

23

Desensitization(receptor level)

(A) Rapid: phosphorylation (sec~min)

(B) Slow: degradation or expression (hours)

24

Desensitization(A) Rapid: phosphorylation (sec~min)

1. Second-messenger kinase (PKA, PKC):uncouple GPCR from G proteinligand independentheterologous desensitization

2. GPCR kinase (GRK): GRK1-GRK7binding of β-arrestin and inhibition of G protein interactionligand-activated or activated conformationhomologous desensitization

25

DesensitizationGPCR kinase (GRK) phosphorylation

NATURE REVIEWS | MOLECULAR CELL BIOLOGY VOLUME 3 | SEPTEMBER 2002 | 639-650

arrestin 1-arrestin 4

26

Recycling or degradation?Desensitization: (B) Degradation

SCIENCE VOL 297 26 JULY 2002

27

Desensitization

a. GTPase-activating proteinsb. accelerate GTP hydrolysisc. >25 members, for selectivity

RGS (regulator of G-protein signaling)

(Post-receptor level)

28

Desensitization by regulator of G-protein signalling (RGS)

NATURE REVIEWS | DRUG DISCOVERY VOLUME 1 | MARCH 2002 | 187-197

RGS2 knockout mice:• T-cell activation• Anxiety• Male aggression

29

G-protein-coupled receptors (GPCRs)

Internalization

30

Internalization

1. Desensitization2. Resensitization3. Signal transduction

Functions:

31

Internalization

• Clathrin-coated pits–β-arrestin

• Caveolae-mediated– Lipid rafts: signalling

• Uncoated vesicles

Types:

32

β-arrestin-dependent internalization of GPCRs

NATURE REVIEWS | NEUROSCIENCE VOLUME 2 | OCTOBER 2001 | 727-733

Function 1: Desensitization

33

Function 2: Resensitization

GRP: GPCR specific phosphatase

Pharmacol Rev 53:1–24, 2001

P

P

P

P

34

NATURE REVIEWS | NEUROSCIENCE VOLUME 2 | OCTOBER 2001 | 727-733

Function 3: Signal transduction

35

TRENDS in Pharmacological Sciences Vol.28 No.8 417

Annu. Rev. Physiol. 2007. 69:511–34

36

GPCR signaling via heterotrimeric G proteins from endosomes

J Biol Chem. 2015 Jan 20. [Epub ahead of print]

37

G-protein-coupled receptors (GPCRs)

G-protein-independent signalling

38

G-protein-independent signalling

Regulation of GPCR Signalling by Scaffold Proteins

39Circ Res. 2002;91:672-680

Scaffold Proteins

1

2

3

40

1. GPCR/PDZ scaffold interaction

Circ Res. 2002;91:672-680

(calcium channel)

PDZ: PSD-95/Discs-large/ZO-1

41

β2 adrenoceptor regulates the Na+-H+ exchanger (NHE)

TRENDS in Biochemical Sciences Vol.26 No.5 May 2001, 291-297

42

2. GPCR/non-PDZ scaffold interaction

Circ Res. 2002;91:672-680

43

Metabotropic glutamate receptor-mediated Ca2+ release

TRENDS in Biochemical Sciences Vol.26 No.5 May 2001, 291-297

Ca2+ release

44

3. GPCR/β-arrestin interaction

Circ Res. 2002;91:672-680

45

β2 Adrenoceptor can mediate the Src kinase pathway

TRENDS in Biochemical Sciences Vol.26 No.5 May 2001, 291-297

46

NATURE | VOL 415 | 10 JANUARY 2002 206-212

47

Transactivation

NATURE REVIEWS | CANCER VOLUME 7 | FEBRUARY 2007 | 85

48Trends Endocrinol Metab. 2006 Mar;17(2):48-54

49Trends Endocrinol Metab. 2006 Mar;17(2):48-54

50

G-protein-coupled receptors (GPCRs)

Oligomerization

51

Signal amplification at the receptor level

NATURE REVIEWS | DRUG DISCOVERY VOLUME 1 | OCTOBER 2002 | 808-820

52

Heterodimerization of the GABAB receptor produces a functional receptor

NATURE REVIEWS | MOLECULAR CELL BIOLOGY VOLUME 3 | SEPTEMBER 2002 | 639-650

53

TRENDS in Pharmacological Sciences Vol.26 No.1 January 2005

Don’t worry ‘B’ happy!:a role for GABABreceptors in anxiety and depressionJohn F. Cryan and KlemensKaupmannNeuroscience Research, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland

54

EMBO reports VOL 7 | NO 11 | 2006, p. 1096

Ligand-independent functions of orphan GPCRs in heterodimers

55

Bivalent and dimeric ligands

NATURE REVIEWS | DRUG DISCOVERY VOLUME 1 | OCTOBER 2002 | 808-820

56

Drug discoveryGPCR Drugs >$20B annual sales

57

GPCR and Diseases

• Obesity• Cardiovascular Disease• Inflammation• Cancer• Diabetes• Alzheimer’s Disaese

58

G-protein-coupled receptors (GPCRs)

Drug screening

59

Key requirements of a ligand screen

• Cell surface expression of GPCRs

• Cellular assays to detect ligand binding

• Libraries of putative natural and synthetic ligands

60

Method for “de-orphanizing” GPCRs

NATURE REVIEWS | MOLECULAR CELL BIOLOGY VOLUME 3 | SEPTEMBER 2002 | 639-650

61

FIRST™ : Functionally Immobilized Receptor Solubilization Technology

Consensus Pharmaceuticals, Inc.

62

CARTConstitutively Active Receptor Technology

Arena Pharmaceuticals, Inc.

63

DISEASE OVERACTIVE KNOWN GPCRs----------------------------------------------------------------Schizophrenia 5HT2A, D4----------------------------------------------------------------Depression 5HT2A----------------------------------------------------------------Hyperthyroidism Thyrotropin----------------------------------------------------------------Hypertension Angiotensin AT1A----------------------------------------------------------------Asthma Adenosine A1----------------------------------------------------------------Melanoma MC-1----------------------------------------------------------------Retinitis Pigmentosa Rhodopsin----------------------------------------------------------------

Diseases - GPCRs

64

Nat Rev Drug Discov. 2011 Jan;10(1):47-60.

65

Nat Rev Drug Discov. 2011 Jan;10(1):47-60.

66

Representation of ‘inactive’ and ‘active’ GPCR conformations

NATURE REVIEWS | DRUG DISCOVERY VOLUME 1 | AUGUST 2002 | 599-608

inactive active

67

CARTConstitutively Active Receptor Technology

Inverse agonists: block ligand-independent activity

Selective molecules: one ligand to multiple receptors

Agonists

Allosteric modulators

(Antagonist: block ligand-dependent activity)

68

Summary

69

Modified from TRENDS in Pharmacological Sciences Vol.22 No.7 July 2001, 368-376

Diversity of G-protein-coupled receptors (GPCRs)

Scaffold proteins

Internalization

signaling

RGS

GRKPKAPKC

70

TRENDS in Pharmacological Sciences Vol.22 No.8 August 2001, 396

Treasures throughout the life-cycle of GPCRs